Detalhe da pesquisa
1.
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Lancet Oncol
; 25(5): e193-e204, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697165
2.
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 23(10): 1308-1320, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36113498
3.
Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study.
Lancet Oncol
; 22(1): 98-106, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387498
4.
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Lancet Oncol
; 20(11): 1531-1543, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31540791
5.
Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London.
Lancet
; 402(10395): 21-24, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37348521
6.
Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer.
World J Urol
; 37(12): 2615-2621, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31346760
7.
Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer.
Curr Oncol Rep
; 21(5): 43, 2019 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30919165
8.
Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.
J Appl Clin Med Phys
; 20(3): 27-36, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756456
9.
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
Lancet
; 399(10328): 905-907, 2022 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090602
10.
Stereotactic radiotherapy and oligometastases - Authors' reply.
Lancet Oncol
; 22(4): e133, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794211
11.
Optimal patient selection for stereotactic body radiotherapy - Authors' reply.
Lancet Oncol
; 20(12): e662, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31797788
12.
Stereotactic body radiotherapy for oligometastases.
Lancet Oncol
; 14(1): e28-37, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23276369
13.
Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity.
Clin Transl Radiat Oncol
; 46: 100769, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586079
14.
Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial.
Int J Radiat Oncol Biol Phys
; 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38499253
15.
The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study.
Cancers (Basel)
; 15(4)2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831631
16.
Interobserver variation in clinical target volume (CTV) delineation for stereotactic radiotherapy to non-spinal bone metastases in prostate cancer: CT, MRI and PET/CT fusion.
Radiother Oncol
; 180: 109461, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634852
17.
The Fraction Size Sensitivity of Late Genitourinary Toxicity: Analysis of Alpha/Beta (α/ß) Ratios in the CHHiP Trial.
Int J Radiat Oncol Biol Phys
; 115(2): 327-336, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35985457
18.
Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram Definition.
Int J Radiat Oncol Biol Phys
; 117(5): 1163-1173, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433374
19.
A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact.
Genet Epidemiol
; 35(6): 549-56, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21769933
20.
Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.
BJU Int
; 109(11): 1636-47, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22077593